Nucleus Network's contribution to medical science

We have worked on dozens of clinical trials of cancer treatments, both in healthy volunteers & cancer patients.

• A biosimilar (a more affordable version of existing medication) that is approved to treat breast cancer in India. This provides people with access to potentially life-saving treatments that would previously have gone without.
• A treatment for melanoma and metastatic non-small-cell lung cancer
• A new administration method (as an IV) of a treatment for brain tumors. While the treatment was already available as a capsule, this caused issues with patients who had difficulty swallowing or who suffered from nausea or vomiting

More information about cancer.

Psoriasis is an autoimmune skin condition that can have a debilitating impact on quality of life. It causes a rash that can be incredibly itchy, interfering with sleep, study, and work.

While there are numerous treatments for psoriasis, many people do not see a long-term improvement from them. There is an ongoing need to develop new options.

We are proud to have worked on the clinical trials for several approved biologics - medication that alters the immune system to disrupt psoriasis. These can provide relief to people who have already tried other treatments but did not see an improvement.

More information about psoriasis.

Hepatitis means inflammation of the liver, and it is caused by five viruses. Chronic hepatitis can damage the liver, eventually leading to liver failure and/or liver cancer.

We have worked on clinical trials of treatments for hepatitis B & C. These have advantages over previously available treatments, like greater antiviral activity.

More information about hepatitis.

Multiple sclerosis is an autoimmune condition that damages the central nervous system (the brain & spinal cord). Symptoms can worsen over time as our own immune system attacks the central nervous system.

We have worked on clinical trials of multiple treatments for multiple sclerosis (MS)

• One treatment can assist adult MS patients with mobility issues, allowing them to walk better
• Other treatments can help slow the progression of neurological decline over time

More information about multiple sclerosis.

Migraines are more than 'just' a headache. The pain can be excruciating, accompanied by nausea, vomiting, and extreme sensitive to light and sound.

Migraines can have a debilitating effect on patients. While there are treatments that can provide relief, we are proud of our work on the first prophylactic treatment.

On average, people who receive this medication have 8 fewer migraine days each month.

More information about migraines.

Type 2 diabetes is a chronic condition that affects how the body processes sugar. Without adequate treatment, it can be fatal.

We worked on a clinical trial of a novel treatment for type 2 diabetes. It works in a similar way to existing treatments, by decreasing glucose production and increasing insulin sensitivity.

The main advantage over similar treatments is that it only needs to be taken once per week instead of once per day, increasing patient compliance.

More information about type 2 diabetes.